Form 4 Tracker
Kiniksa Pharmaceuticals International, plc
KNSA

43 insider filings · Latest: Sep 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 14, 2025Apr 14 8:56 PMTessari Eben
Proposed Sale
12,000$20.49$245.9K—

View →

Mar 17, 2025Mar 17 9:29 PMRagosa Mark
Proposed Sale
36,287$23.10$838.2K—

View →

Mar 12, 2025Mar 12 8:47 PMMegna Michael R
Proposed Sale
9,051$22.45$203.2K—

View →

Mar 12, 2025Mar 12 8:04 PMRagosa Mark
Proposed Sale
36,372$22.25$809.4K—

View →

Mar 10, 2025Mar 10 9:13 PMTessari Eben
Proposed Sale
12,409$21.06$261.3K—

View →

Feb 10, 2025Feb 10 10:37 PMTessari Eben
Proposed Sale
14,000$19.57$274.0K—

View →

Jan 13, 2025Jan 13 10:27 PMTessari Eben
Proposed Sale
14,000$18.24$255.4K—

View →

Dec 16, 2024Dec 16 10:17 PMTessari Eben
Proposed Sale
23,017$20.44$470.4K—

View →

Dec 3, 2024Dec 3 10:25 PMRagosa Mark
Proposed Sale
72,754$21.25$1.5M—

View →

Nov 27, 2024Nov 27 10:13 PMMegna Michael R
Proposed Sale
17,697$22.45$397.3K—

View →

Nov 18, 2024Nov 18 10:50 PMTessari Eben
Proposed Sale
17,000$21.04$357.6K—

View →

Nov 6, 2024Nov 6 9:11 PMPatel Sanj K
Proposed Sale
89,561$23.00$2.1M—

View →

Oct 15, 2024Oct 15 8:57 PMTessari Eben
Proposed Sale
17,000$26.87$456.8K—

View →

Sep 23, 2024Sep 23 9:02 PMTessari Eben
Proposed Sale
17,500$24.99$437.3K—

View →

Sep 3, 2024Sep 3 9:17 PMMoat Ross
Proposed Sale
68,506$26.12$1.8M—

View →

Sep 3, 2024Sep 3 9:16 PMPaolini John F.
Proposed Sale
90,217$26.12$2.4M—

View →

Aug 27, 2024Aug 27 9:17 PMTessari Eben
Proposed Sale
17,500$26.91$470.9K—

View →

← Previous

Page 5 of 5

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Apr 7, 2026Apr 8 8:39 PMRoss MoatCHIEF OPERATING OFFICER
Option Exercise
2,477—0(D)

View →

Apr 7, 2026Apr 8 8:38 PMMichael R MegnaCHIEF ACCOUNTING OFFICER
Option Exercise
3,932—0(D)

View →

Apr 6, 2026Apr 8 8:34 PMBarry D QuartDirector
Option Exercise
6,901$14.3326,336(D)

View →

Apr 1, 2026Apr 3 8:41 PMEben TessariCHIEF STRATEGY OFFICER
Option Exercise
5,975—7,371(D)

View →

Apr 1, 2026Apr 3 8:41 PMEben TessariCHIEF STRATEGY OFFICER
Grant/Award
58,100$48.1316,600(D)

View →

Apr 1, 2026Apr 3 8:40 PMMark RagosaCHIEF FINANCIAL OFFICER
Grant/Award
54,550$48.1315,600(D)

View →

Apr 1, 2026Apr 3 8:40 PMMark RagosaCHIEF FINANCIAL OFFICER
Option Exercise
5,187—5,536(D)

View →

Apr 1, 2026Apr 3 8:39 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
21,327—25,826(D)

View →

Apr 1, 2026Apr 3 8:39 PMSanj K PatelDirector, CHAIRMAN & CEO
Grant/Award
210,300$48.1360,100(D)

View →

Apr 1, 2026Apr 3 8:37 PMJohn F. PaoliniCHIEF MEDICAL OFFICER
Option Exercise
5,831—7,371(D)

View →

Apr 1, 2026Apr 3 8:37 PMJohn F. PaoliniCHIEF MEDICAL OFFICER
Grant/Award
46,850$48.1313,400(D)

View →

Apr 1, 2026Apr 3 8:35 PMRoss MoatCHIEF OPERATING OFFICER
Grant/Award
64,700$48.1318,500(D)

View →

Apr 1, 2026Apr 3 8:35 PMRoss MoatCHIEF OPERATING OFFICER
Option Exercise
5,808—7,371(D)

View →

Apr 1, 2026Apr 3 8:34 PMMichael R MegnaCHIEF ACCOUNTING OFFICER
Grant/Award
25,550$48.137,300(D)

View →

Apr 1, 2026Apr 3 8:34 PMMichael R MegnaCHIEF ACCOUNTING OFFICER
Option Exercise
7,564—7,931(D)

View →

Mar 9, 2026Mar 11 8:38 PMMark RagosaCHIEF FINANCIAL OFFICER
Option Exercise
36,722$26.7422,790(D)

View →

Mar 2, 2026Mar 4 9:40 PMJohn F. PaoliniCHIEF MEDICAL OFFICER
Option Exercise
40,000$10.3658,424(D)

View →

Feb 12, 2026Feb 12 9:34 PMBarry D QuartDirector
Option Exercise
2,690$15.470(D)

View →

Feb 10, 2026Feb 12 9:34 PMBarry D QuartDirector
Option Exercise
110$15.472,690(D)

View →

Feb 9, 2026Feb 11 9:38 PMMark RagosaCHIEF FINANCIAL OFFICER
Option Exercise
10,845$16.900(D)

View →